Latest news with #KimJae-woo
Korea Herald
13-03-2025
- Health
- Korea Herald
Samsung invests $10m in US Alzheimer's diagnostics firm C2N
Samsung C&T announced Thursday that its Life Science Fund, established in collaboration with Samsung Biologics, Samsung Bioepis and Samsung Venture Investment, will invest $10 million in C2N Diagnostics, a US-based Alzheimer's testing company. C2N specializes in analyzing protein biomarkers — biological indicators used to track disease progression and drug responses — found in extremely low concentrations in the blood. Leveraging this technology, the company has developed a blood test for diagnosing Alzheimer's disease and has participated in global clinical trials for Alzheimer's treatments and other central nervous system disorders. C2N's blood test provides a safer and more cost-effective alternative to traditional diagnostic methods, such as amyloid PET-CT scans and cerebrospinal fluid tests. The test enables precise measurement of multiple Alzheimer's-related proteins, including amyloid-beta, making Alzheimer's diagnoses more accessible and convenient. The company plans to seek FDA approval for its test within this year. C2N CEO Joel Braunstein said the investment will support global expansion efforts. 'C2N Diagnostics has the potential to lead pharmaceutical research support and related services,' said Kim Jae-woo, vice president of Samsung C&T's life science division. 'This investment secures Samsung's foothold in the sector.' The Life Science Fund, managed by Samsung Venture Investment, was established with 240 billion won ($180 million) to foster next-generation biotechnologies. Previous investments include Araris Biotech and AimedBio, which specialize in antibody-drug conjugates, and Generate Biomedicines, which develops protein-based biopharmaceuticals using machine learning.
Korea Herald
05-03-2025
- Business
- Korea Herald
Banking sector sees minimal impact from Homeplus' debt restructuring
Homeplus' W2tr debt is manageable, no systemic risk: analysts As South Korea's retail industry grapples with the shock of its second-largest supermarket chain entering court rehabilitation, market watchers largely believe that Homeplus' debt isn't substantial enough to trigger a sector-wide crisis or destabilize the local financial industry. Industry reports on Wednesday show that Homeplus holds around 2 trillion won ($1.37 billion) in debt from local financial institutions, with Meritz Financial Group being the largest creditor at 1.2 trillion won, followed by Hanwha Securities & Investment at 150 billion won and the banking sector at a combined 110 billion won. Homeplus' exposure came into focus as it began court-led rehabilitation on Tuesday, a preemptive move to address a potential funding crunch following a recent credit rating downgrade. The court immediately approved and initiated the procedure. The largest single creditor is Meritz Financial Group, which holds approximately 1.2 trillion won in mortgage loans extended to Homeplus by three of its subsidiaries, secured through beneficiary certificates from a trust contract between Homeplus and a real estate trust company. Despite the substantial amount, Meritz remains confident in Homeplus' ability to recover. "The collateral value is estimated at around 5 trillion won, and we anticipate no issues in recovering the funds," a Meritz official said, adding that the exercise of its senior beneficiary rights is unrelated to the rehabilitation process. Entrusted assets are regarded as the trustee's property and, therefore, are not subject to the debtor's rehabilitation process. Korea Investors Service, the Korean arm of global credit ratings agency Moody's, also assessed that Homeplus' rehabilitation process "will have limited impact" on Meritz, noting that the real estate collateral shows a relatively "good" loan-to-value ratio. The banking industry's exposure to Homeplus, totaling 110 billion won — comprised of 55 billion won from KB Kookmin Bank, 28 billion won from Shinhan Bank, and 27 billion won from Woori Bank, all in short-term loans — is expected to have a limited impact from the retailer's credit event. 'These three banks' total combined loans amount to about 983 trillion won, with their loans to Homeplus accounting for just 0.01 percent of the total,' said Kim Jae-woo, a researcher at Samsung Securities, adding that even with the retailer's loan provisioned, the impact on lenders' quarterly earnings would be minimal, around 1-2 percent. While concerns grow that Homeplus' credit issue could trigger an industrywide crisis, similar to Tmon and WeMakePrice's liquidity crunch last year, market watchers see this as unlikely. 'The short-term impact on the retail industry is expected to be limited,' said NH Investment & Securities analyst Joo Young-hoon. 'Homeplus stated it will continue normal operations across all retail channels regardless of the corporate rehabilitation process, meaning there will be no change in the industry's competitive landscape.' Homeplus said it initiated rehabilitation preemptively, unlike Tmon and WeMakePrice, which were already struggling with capital erosion when it applied for corporate rehabilitation. The Seoul Bankruptcy Court also acknowledged this when it approved the rehabilitation process on Tuesday, opting not to appoint a trustee, citing Homeplus' scale and transaction volume. Industy rivals such as E-Mart may even benefit from the situation, analysts anticipated, as Homeplus is expected to see further declines in operating revenue and market share as it goes through the debt restructuring process. Homeplus is set to submit its rehabilitation plan by June 3. Meanwhile, Korea Ratings downgraded Homeplus' credit rating from A3- to D on Wednesday, following its filing for corporate rehabilitation. This comes just days after Korea Investors Service downgraded the rating from A3 to A3-.
